Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease-Reference-Cited by-同舟云学术

Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease

Published:2020 Issue: Volume: Page:85-94
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Reed Damon R.,Hingorani Pooja,Anderson Peter M.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-43032-0_8

Reference29 articles.

1. Whelan J, Hook J, Bielack SS et al (2012) EURAMOS-1 study: recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma. ASCO Meet Abstr 30(15_suppl):10081

2. Kempf-Bielack B, Bielack SS, Jurgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 23(3):559–568. https://doi.org/10.1200/JCO.2005.04.063. [published Online First: Epub Date]|

3. Bielack SS, Kempf-Bielack B, Branscheid D et al (2009) Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 27(4):557–565. https://doi.org/10.1200/jco.2008.16.2305. [published Online First: Epub Date]|

4. Briccoli A, Rocca M, Salone M et al (2005) Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 104(8):1721–1725. https://doi.org/10.1002/cncr.21369. [published Online First: Epub Date]|

5. Lagmay JP, Krailo MD, Dang H et al (2016) Outcome of patients with recurrent osteosarcoma enrolled in seven phase II trials through Children’s Cancer Group, Pediatric Oncology Group, and Children’s Oncology Group: learning from the past to move forward. J Clin Oncol. https://doi.org/10.1200/JCO.2015.65.5381. [published Online First: Epub Date]|

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy;Scientific Reports;2023-11-17

2. miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3;Journal of Oncology;2022-09-26

3. Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells;Frontiers in Oncology;2021-04-27